Scientists hunt for genetic clues to aortic aneurysm risk
NCT ID NCT01194362
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study collected blood and tissue samples from 91 adults with aortic valve disease to look for genetic differences that might explain why some develop aortic aneurysms. Researchers compared gene activity in people with bicuspid valves, tricuspid valves, and healthy controls. The goal is to better understand the disease, not to test a treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors understand why some people with aortic valve disease develop dangerous aneurysms, potentially leading to better screening or treatments.
- What could go wrong
- This is an observational study that only looks at genetic patterns, not a treatment. It may not lead to any direct medical changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
91 people
The number who actually took part.
- Started
-
Jun 2010
- Finished
-
Sep 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Hospital facility
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients \> or = to 18 years of age * Presenting with aortic stenosis and to undergo elective aortic valve replacement or repair with or without aortic aneurysm dilation repair * Able to sign informed consent document Exclusion Criteria: * Patients unable to provide informed consent for any reason * Patients with predominant aortic regurgitation valve disease * Patients with other known connective tissue disorders (such as Marfan's Syndrome, Ehlers-Danlos Syndrome)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Aortic stenosis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Heart Hospital Baylor Plano
Plano, Texas, 75093, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI turns routine heart tracings into an early warning for a silent valve disease
- Heart valve implants tested for leaky aortic valves
- Can a new heart valve offer a safer fix for aortic stenosis?
- Can Open-Heart surgery outperform a Tube-Based valve fix?
- Can a new heart valve restore quality of life?
- Does replacing a heart valve clear fluid from the lungs?